3rd Quarter - Report

VAN NESS FELDMAN, LLP for MCKESSON CORPORATION

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Legislation regarding potential LIFO issue

LobbyistCovered position, as disclosed
HOWARD J FELDMAN —
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

H.R. 1392, to amend Title XVIII of the Social Security Act S. 1221, to amend Title XVIII of the Social Security Act H.R. 759, Food and Drug Administration Globalization Act of 2009 S. 525, a bill to amend the Federal Food, Drug and Cosmetic Act S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 882, Drug and Device Accountability Act of 2009 S. 301, to amend the Title XI of the Social Security Act Health information technology issues

LobbyistCovered position, as disclosed
RICHARD A AGNEW —
HOWARD J FELDMAN —
BEN LEE MCMAKIN —
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: H.R. 759 (111th), S. 882 (111th), S. 1232 (111th), S. 525 (111th), S. 301 (111th), S. 80 (111th), S. 1221 (111th), H.R. 1392 (111th)

Veterans VET

Education regarding the Department of Veterans Affairs Pharmaceutical Prime Vendor contract.

LobbyistCovered position, as disclosed
BEN LEE MCMAKIN —
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

S. 1221, To amend title XVIII of the Social Security Act H.R. 1392, To amend title XVIII of the Social Security Act

LobbyistCovered position, as disclosed
RICHARD A AGNEW —
HOWARD J FELDMAN —
BEN LEE MCMAKIN —
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 1392 (111th), S. 1221 (111th)

Pharmacy PHA

H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009

LobbyistCovered position, as disclosed
RICHARD A AGNEW —
HOWARD J FELDMAN —
BEN LEE MCMAKIN —
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA)

Bills named: S. 1232 (111th), S. 80 (111th), H.R. 3108 (111th)

Financial Institutions/Investments/Securities FIN

Proxy access provisions of H.R. 4173, Restoring American Financial Stability Act of 2010

LobbyistCovered position, as disclosed
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 4173 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.